- Home
- IRLA vs GALT Comparison
IRLA vs GALT Comparison
Compare IRLA & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$33.81
N/A
Current Price
$3.45
Company Overview
Basic Information| Metric | IRLA | GALT |
|---|---|---|
| Founded | 2012 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 360.3M | 397.3M |
| IPO Year | 2019 | 2008 |
Fundamental Metrics
Financial Performance| Metric | IRLA | GALT |
|---|---|---|
| Price | $33.81 | $3.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $75.00 | N/A |
| AVG Volume (30 Days) | 74.6K | ★ 191.4K |
| Earning Date | 11-20-2026 | 11-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 36.84 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.90 | $2.03 |
| 52 Week High | $41.00 | $7.13 |
Technical Indicators
Market Signals| Indicator | IRLA | GALT |
|---|---|---|
| Relative Strength Index (RSI) | 56.26 | 49.26 |
| Support Level | $28.14 | $2.71 |
| Resistance Level | $34.27 | $4.10 |
| Average True Range (ATR) | 3.91 | 0.28 |
| MACD | -0.20 | 0.00 |
| Stochastic Oscillator | 48.60 | 68.75 |
Price Performance
Historical Comparison IRLA
GALT
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.